|
|
Active Control Non-Inferiority Studies: Theory, Assay Sensitivity, Choice of Margin Robert J. Temple, M.D. Associate Director for Medical Policy
Understanding the Concept of Equivalence and Non-Inferiority Trials CM Gibson, 2000 Terminology The term active-control trial refers to all studies in which the ...
noninferioritytrials.ppt - Search
1 . Non-inferiority Trials – Hypotheses and Analyses . Gang Chen 1, Yongcheng Wang 2, George Chi 1, Kevin Liu 1 . 1 Clinical Biostatistics, Global Drug Development ...
Chen BASS_X1_2004_final.ppt - Search
trials
hypotheses
analyses
yongcheng
george
kevin
clinical
global
development
1 . Active Control Non-Inferiority Trial – The Hypothesis . George Y.H. Chi, Gang Chen, Kevin Liu. Clinical Biostatistics. Global Drug Development, J&J PRD
Chi Talk at BASS - Final-Nov 1,2004.ppt - Search
issues that plague non-inferiority trials past and future ralph b. d’agostino, sr. boston university harvard clinical research institute objectives review issues ...
P08_Dagostino_NonInferiority.ppt - Search
issues
plague
future
ralph
boston
university
harvard
research
institute
objectives
review
Challenges of Non-Inferiority Trial Designs R. Sridhara, Ph.D. Terminology Superiority = Drug T better than Placebo (P) or T better than Active Control (C) C may or ...
2006-4256s-01-02-FDA-Sridhara.ppt - Search
Decision-Theoretic Views on Switching Between Superiority and Non-Inferiority Testing. Peter Westfall. Director, Center for Advanced Analytics and Business Intelligence
SomeViewsonNon-InferiorityTesting.ppt - Search
decision-theoretic
views
switching
between
superiority
peter
center
advanced
analytics
business
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group ...
Budesonide.ppt - Search
The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA, Rockville MD 20850
ParallelSession3C.ppt - Search
application
propensity
score
analysis
-randomized
device
regulatory
perspective
lilly
rockville
A Randomised, Non-Inferiority Trial Stephan Windecker, Patrick W. Serruys, Simon Wandel, Pawel Buszman, Stanislaw Trznadel, Axel Linke, Karsten Lenk,
LEADERS_ESC08.ppt - Search
Pedagogical Example 0 Pedagogical Example 0 (cont’d) Example 1 Two-Arm Non-Inferiority Trial: Binary Endpoint Example 1 No Adaptation: Operating Characteristics Example ...
... with skin and skin structure infections Response: cure and failure (not cure) after 4 to 8 days Consider three situations: Equality of mean cure rates Non-inferiority or ...
EPP246lecture4.ppt - Search
Non-inferiority trial – a trial with the primary objective of showing that the response to the investigational product is not clinically inferior to a ...
LECTURE 19 2010.ppt - Search
trial
primary
objective
showing
response
investigational
product
clinically
Non-Inferiority Trial David R. Holmes, MD Vivek Y. Reddy, MD Zoltan G. Turi, MD Shephal K. Doshi, MD Horst Sievert, MD Maurice Buchbinder, MD Christopher M. Mullin
PROTECT AF.ppt - Search
May not be necessary to show superiority Trial Design Superiority, Equivalence, or Non-inferiority Superiority ideal if a significant improvement over conventional ...
Outpatient Versus Inpatient Treatment for Patients with Acute Pulmonary Embolism: an International, Open-label, Randomised, Non-inferiority trial
Outpt-vs-Inpt-PE-management-final-version.pttx_1.ppt - Search
Placebo Control vs Active Control Trials Hypothesis pertaining to superiority Hypothesis pertaining to equivalence Hypothesis pertaining to non-inferiority Superiority of ...
Types of Hypotheses Test for equality H0: u1 = u0 vs H1: u1 != u0, 1: Rx, 0: control Test for non-inferiority H0: u0 – u1 >= delta vs u0– u1 < delta u0: standard ...
EPP246lecture3.ppt - Search
Equivalence Non-inferiority Effectiveness Pragmatic Patient preference Explanatory vs pragmatic Efficacy vs effectiveness Pragmatic, effectiveness What would be ...
Different types of trial design.ppt - Search
effectiveness
pragmatic
patient
preference
explanatory
efficacy
would
... sites from Feb 2003-July 2005 GuardWire or FilterWire (EX/EZ*) N=357 SPIDER/SpideRX* N=375 Randomization stratified by planned IIbIIIa use ASA & Plavix Non-Inferiority ...
SPIDER Trial.ppt - Search
|
Hot Documents omap-l1fibrynoliza problem-of-ode-regarding-radio biyo-ekolojik sonic israelites preadolescentes distruggere raadgevende fumos |